Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-30

Clinical Trial Update: Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone [NA]

View source ↗

Summary

A clinical trial update indicating Derm-Maxx is being studied for diabetic foot ulcers not responsive to standard care, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Derm-Maxx

Snippet

Sponsor: Capsicure, LLC | Conditions: Diabetic Foot Ulcer | NA | Status: RECRUITING